| Patent application number | Description | Published |
|---|
| 20080289894 | Control Apparatus and Control Method for Vehicle - A distribution ratio determining unit determines the distribution ratio for distributing a required torque based on a static load distribution ratio, when the sign of the required torque is negative. The distribution ratio determining unit determines the distribution ratio based on a dynamic load distribution ratio, when the sign of the required torque is positive. The distribution ratio determining unit determines the distribution ratio based on the static load distribution ratio and the dynamic load distribution ratio, when the sign of the required torque changes. Thus, even when the sign of the required torque changes, it is possible to prevent the driving forces for a plurality of wheels of a vehicle from changing discontinuously. | 11-27-2008 |
| 20090088919 | CONTROL DEVICE FOR VEHICLE, AND CONTROL METHOD THEREOF - A drive force control portion ( | 04-02-2009 |
| 20090105043 | Power Output Apparatus, Control Method of Power Output Apparatus, and Vehicle Equipped With Power Output Apparatus - The drive control of the invention executed in a vehicle sets a correction coefficient keg, based on an intake air temperature and an atmospheric pressure reflecting the density of intake air supplied to an engine, and multiplies a power demand required for the vehicle by the set correction coefficient keg to specify a target engine power, which is to be output from the engine. The engine and two motors are then controlled to ensure output of the specified target engine power from the engine and output of a torque demand, which depends upon an accelerator opening. The varying density of the intake air may cause output of excessive power from the engine or output of insufficient power from the engine. A battery is charged or discharged to compensate for the excessive power output from the engine or for the insufficient power output from the engine. The drive control of the invention effectively deals with the environmental change and prevents the battery from being excessively charged with an unexpectedly high electric power or from being excessively discharged to supply an unexpectedly high electric power. | 04-23-2009 |
| 20090118980 | CONTROL APPARATUS AND METHOD FOR INTERNAL COMBUSTION ENGINE - An engine ECU ( | 05-07-2009 |
| Patent application number | Description | Published |
|---|
| 20080275047 | TETRAHYDRO-NAPHTHALENE DERIVATIVES - This invention relates to tetrahydro-naphthalene derivatives and salts thereof which are useful as an active ingredient of pharmaceutical preparations. The tethrahydro-naphthalene derivatives of the present invention have excellent activity as VR1 antagonist and useful for the prophylaxis and treatment of diseases associated with VR1 activity, in particular for the treatment of urinary incontinence, overactive bladder, urge urinary incontienence, chronic pain, neuropathic pain, post-operative pain, rheumatoid arthritic pain, neuralgia, neuropathies, algesia, nerve injury, ischaemia, neurodegeneration, stroke, inflammatory disorders, asthma and COPD. | 11-06-2008 |
| 20090209514 | Tetrahydro-Naphthalene Derivatives as Vanilloid Receptor Antagonists - This invention relates to tetrahydro-naphthalene derivatives and salts thereof which is useful as an active ingredient of pharmaceutical preparations. The tetrahydronaphthalene derivatives of the present invention have an excellent activity as VR1 antagonist and useful for the prophylaxis and treatment of diseases associated with VR1 activity, in particular for the treatment of urinary incontinence, urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, algesia, nerve injury, ischaemia, neurodegeneration, stroke, inflammatory disorders, asthma and COPD. | 08-20-2009 |
| 20090298811 | BENZIMIDAZOLONE DERIVATIVES - This invention relates to compounds and methods for the treatment of a condition mediated by CB1 receptor activity in a mammalian subject including a human, which comprises administering to a mammal in need of such treatment a therapeutically effective amount of the compound of formula (I) or pharmaceutically acceptable salts thereof, wherein: A, B, R | 12-03-2009 |
| 20110178088 | TETRAHYDRO-NAPHTHALENE DERIVATIVES - This invention relates to tetrahydro-naphthalene derivatives and salts thereof which are useful as an active ingredient of pharmaceutical preparations. The tetrahydro-naphthalene derivatives of the present invention have excellent activity as VR1 antagonist and useful for the prophylaxis and treatment of diseases associated with VR1 activity, in particular for the treatment of urinary incontinence, overactive bladder, urge urinary incontinence, chronic pain, neuropathic pain, post-operative pain, rheumatoid arthritic pain, neuralgia, neuropathies, algesia, nerve injury, ischaemia, neurodegeneration, stroke, inflammatory disorders, asthma and COPD. | 07-21-2011 |
